The Problem: Patients Are Stuck
If you've ever struggled to remember when your last seizure happened, or felt frustrated that your doctor only sees a snapshot of your brain — you're not alone. 98% of seizure data today relies on memory alone.
The Solution: Ally 100
Instead of asking "How have you been feeling?" your doctor will know exactly what's been happening — 24/7, for up to 3 years.
Seamless Outpatient Procedure
A simple outpatient procedure. Then your brain data works for you — automatically, continuously, for years.
Implant
15-minute minimally invasive procedure under local anesthesia at ambulatory surgery center
Monitor
Device continuously records EEG data subcutaneously with moderate to high signal resolution
Transmit
Data wirelessly transmitted to patient's smartphone and uploaded to secure cloud
Analyze
AI/ML algorithms detect seizures, predict episodes, and provide actionable insights
Gold-Standard Accuracy at a Fraction of the Cost
| Feature | NVT (Ally 100) | Routine EEG | Video EEG | Intracranial |
|---|---|---|---|---|
| Duration | ~1,095 days | 1 hour | 3-7 days | 5-7 days |
| Location | Anywhere | Office | Hospital | ICU/EMU |
| Invasiveness | Minimal | Non-invasive | Non-invasive | Highly invasive |
| Cost per Day | ~$20 | $500/study | ~$9,000/day | >$9,000/day |
| Seizure Detection | Very High | Very Low | Mod. Low | High |
The Only Minimally Invasive Brain Computer Interface
| Feature | NVT | Wearables | Invasive BCI |
|---|---|---|---|
| Fully Implanted | |||
| Chronic Monitoring | |||
| General Purpose | |||
| Low Risk / Low Cost | |||
| Scalable / Compliant |
Pathway to FDA Approval
We're on an accelerated path to bring this technology to patients who need it most.
Human Proof of Concept
Over 150 patients validated high sensitivity and specificity
Canine Implants
Successful pre-clinical canine implants with reliable data transmission
FDA Pre-IDE Meeting
De novo pathway with low approval bar granted
FDA Approval
First objective seizure burden biometric approval
Frequently Asked Questions
Answers to common questions about the Ally 100 and continuous brain monitoring.
What is the NeuroView Ally 100?+
The Ally 100 is the world's first minimally invasive, always-on EEG implant designed for continuous seizure monitoring in epilepsy patients. It records brain activity 24/7 for up to 1,095 days (3 years) and transmits data wirelessly to a smartphone app.
How is the Ally 100 implanted?+
The Ally 100 is implanted through a 15-minute minimally invasive outpatient procedure under local anesthesia. The device is placed subcutaneously (under the skin) on the skull, requiring no brain surgery. Patients can go home the same day.
How much does continuous brain monitoring cost compared to hospital EEG?+
The Ally 100 costs approximately $20 per day of monitoring, compared to over $9,000 per day for inpatient video EEG monitoring. Over its 3-year lifespan, it provides continuous data at a fraction of the cost of even a single hospital stay.
Can the Ally 100 predict seizures before they happen?+
Yes. The Ally 100's AI algorithms analyze continuous EEG patterns to identify pre-seizure biomarkers, providing patients and clinicians with early warning predictions. Clinical data shows the system can detect seizure risk hours before an event occurs.
Does NeuroView have FDA approval?+
NeuroView Technology has received FDA Breakthrough Device Designation, which provides an accelerated pathway to approval. The company has completed human proof-of-concept studies with over 150 patients and successful pre-clinical canine implants.
Who is a candidate for the Ally 100?+
The Ally 100 is designed for patients with epilepsy who need continuous seizure monitoring, particularly those with drug-resistant epilepsy, patients being evaluated for surgery, or those whose seizure frequency is difficult to quantify with traditional methods.